header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

TITANIUM HEMIARTHROPLASTY FOR THE HALLUX METATARSOPHALENGEAL JOINT



Abstract

Introduction and Aims: To evaluate the clinical outcome of Titanium hemiarthroplasty in the management of hallux metatarsophalangeal joint arthritis.

Method: Fifty-five joints in 46 patients were treated surgically with Titanium implant for arthritic hallux meta-tarsophaelangeal joints. There were 35 women and 11 men. The pathological indications were hallux rigidus (74%), rheumatoid arthritis (10%) and degenerative changes associated with hallux valgus (16%). Six cases were done as a revision of sialastic to titanium prosthesis due to severe silicone synovitis.

Results: The mean age was 60 (range 43–76) years, and the mean follow-up was 56 (range 28–86) months. The mean time taken to get back to normal activities is 36.6 (range 21–90) days. The mean range of motion achieved was 32 (range 20–64) degrees and the relief of pain was excellent or good in 86% of the patients. There were no surgical complications in the form of infection, osteolysis or instability. The synovitis in the revision group has subsided.

Conclusions: The clinical results of Titanium hemiarthroplasty were good. The advantages of this procedure were preservation of joint movement and good pain relief.

These abstracts were prepared by Editorial Secretary, George Sikorski. Correspondence should be addressed to Australian Orthopaedic Association, Ground Floor, The William Bland Centre, 229 Macquarie Street, Sydney, NSW 2000, Australia.

None of the authors are receiving any financial benefit or support from any source.